Janet McGill, MD is Professor of Medicine at Washington University School of Medicine, director of the Fellowship in Endocrinology, Diabetes and Metabolism, and attending physician at Barnes-Jewish Hospital in St. Louis, Missouri. She has been active in diabetes research for over 25 years, starting with the Diabetes Control and Complications Trial and the Captopril in Diabetic Nephropathy study, followed by the DPP, RENAAL and over 200 clinical trials in both type 1 and type 2 diabetes, hypertension, hyperlipidemia and related disorders. The majority of these trials were funded by industry, testing new molecules for their safety and efficacy or gaining a better understanding of the use of existing therapies. She has been a co-PI in two large single-center studies of myocardial fuel metabolism in diabetes and a study of genotoxic stress in patients with the metabolic syndrome. She is currently the Washington University PI for the GRADE study. Additionally, Dr. McGill has served on numerous steering committees, clinical endpoint committees and data safety monitoring boards. Working in partnership with local and national leaders in diabetes, both in academics and in industry, has contributed to an interesting and productive career. Dr. McGill received the Distinguished Clinician Award for Washington University in 2014, and would describe her passions as both studying new therapies and providing optimal care for her patients with diabetes.